ClassID:

109145

C12N2310/14 - page 20 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Type of nucleic acid interfering N.A.

Recent Application in this class:
#5701
20150337316
2015-11-26

Phosphoribosyl pyrophosphate synthetase 2 (PRPS2) as a therapeutic target in cancer treatment

#5702
20150337315
2015-11-26

COMPOSITIONS AND METHODS TARGETING SIGNALING BY THE G PROTEIN BETA-GAMMA SUBUNIT FOR THE TREATMENT OF ASTHMA

#5703
20150337313
2015-11-26

MUCOSAL HEALING PROMOTER

#5704
20150337307
2015-11-26

Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene

#5705
20150337306
2015-11-26

Methods and compositions for the production of siRNAs

#5706
20150337304
2015-11-26

Oligomeric compounds and compositions for use in modulation of small non-coding RNAs

#5707
20150337302
2015-11-26

Biological control of coleopteran pests

#5708
20150337280
2015-11-26

Polypeptides Having Cellulolytic Enhancing Activity And Polynucleotides Encoding Same

#5709
20150337030
2015-11-26

METHODS TO TREAT ALZHEIMER'S DISEASE USING APOE INHIBITORS

#5710
20150335739
2015-11-26

METHODS FOR TREATING INFLAMMATION

#5711
20150335702
2015-11-26

Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers

#5712
20150335683
2015-11-26

METHODS FOR PRODUCING DOPAMINERGIC NEURONS AND USES THEREOF

#5713
20150335674
2015-11-26

LDH inhibitors as treatment for fibrosis and fibrotic-related disorders

#5714
20150335608
2015-11-26

Methods of treating an overweight subject

#5715
20150329871
2015-11-19

Plant in which expression of a clathrin and/or coatomer subunit is suppressed or inhibited, a method for increasing the production of plant biomass and a method for producing a plant

#5716
20150329867
2015-11-19

Pharmaceutical Compositions and Diagnostic Methods for Inflammatory Skin Diseases, Disorders or Conditions

#5717
20150329866
2015-11-19

Methods of treating ischemia-reperfusion injury with siRNAs

#5718
20150329864
2015-11-19

DESIGN OF OLIGONUCLEOTIDE ANALOGS AS THERAPEUTIC AGENTS

#5719
20150329862
2015-11-19

Gene Silencing by Single-Stranded Polynucleotides

#5720
20150329858
2015-11-19

LONG NON-CODING RNA USED FOR ANTICANCER THERAPY

#5721
20150329857
2015-11-19

RNA INTERFERENCE TO ACTIVATE STEM CELLS

#5722
20150329644
2015-11-19

Peptides useful for modulating histone demethylase function

#5723
20150328248
2015-11-19

Apoptosis-inducing agent

#5724
20150323538
2015-11-12

Systems and methods for diagnosing and treating cancer

#5725
20150323536
2015-11-12

SATB1: A DETERMINANT OF MORPHOGENESIS AND TUMOR METASTATIS

#5726
20150322530
2015-11-12

Molecular signatures of ovarian cancer

#5727
20150322468
2015-11-12

METHOD OF PRODUCING BIOFUEL USING MICROALGAE CULTURES

#5728
20150322456
2015-11-12

Nucleic acid molecules that confer resistance to coleopteran pests

#5729
20150322455
2015-11-12

SEC23 NUCLEIC ACID MOLECULES THAT CONFER RESISTANCE TO COLEOPTERAN AND HEMIPTERAN PESTS

#5730
20150322438
2015-11-12

Modified oligonucleotides for telomerase inhibition

#5731
20150322437
2015-11-12

Modified oligonucleotides for telomerase inhibition

#5732
20150322435
2015-11-12

Formulations for treating amyloidosis

#5733
20150322433
2015-11-12

Post-synthetic orthogonal amidation plus metal catalyzed azide-alkyne cycloaddition click chemistry on siRNA

#5734
20150322432
2015-11-12

Compositions and methods for functional nucleic acid delivery

#5735
20150322431
2015-11-12

Methods and compositions of improved modified siRNA

#5736
20150322430
2015-11-12

Treatment of B-cell lymphoma with microRNA

#5737
20150322428
2015-11-12

COMPOUNDS AND METHODS FOR IMPROVED CELLULAR UPTAKE OF ANTISENSE COMPOUNDS

#5738
20150322427
2015-11-12

Cancer treatment and immune system regulation through FAT10 pathway inhibition

#5739
20150322131
2015-11-12

Production of therapeutic proteins in genetically modified mammalian cells

#5740
20150320835
2015-11-12

Manipulation of hairy and enhancer of split 3 (Hes3) and its regulators/mediators as an anti-cancer strategy

#5741
20150316538
2015-11-05

Identification of an inhibitor of iRhom1 or an inhibitor of iRhom2

#5742
20150315662
2015-11-05

Mantle phenotype detection in palm

#5743
20150315642
2015-11-05

Methods and compositions for detection of targets for autoimmune disease

#5744
20150315592
2015-11-05

Transferrin/transferrin receptor-mediated siRNA delivery

#5745
20150315589
2015-11-05

Methods of inhibiting cancer stem cells with HMGA1 inhibitors

#5746
20150315584
2015-11-05

Compositions and methods for silencing apolipoprotein C-III expression

#5747
20150315583
2015-11-05

Methods and compositions for the specific inhibition of CKAP5 by double-stranded RNA

#5748
20150315581
2015-11-05

Signal activatable constructs and related components compositions methods and systems

#5749
20150315579
2015-11-05

DOUBLE STRAND COMPOSITIONS COMPRISING DIFFERENTIALLY MODIFIED STRANDS FOR USE IN GENE MODULATION

#5750
20150315578
2015-11-05

Identification of novel genes coding for small temporal RNAs

#5751
20150315577
2015-11-05

Method for inhibiting calcification of a macrophage-derived matrix vesicle

#5752
20150315576
2015-11-05

GENETIC DEVICE FOR THE CONTROLLED DESTRUCTION OF DNA

#5753
20150315575
2015-11-05

Compositions and methods for selective delivery of oligonucleotide molecules to cell types

#5754
20150315559
2015-11-05

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#5755
20150315261
2015-11-05

Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor

#5756
20150315226
2015-11-05

Disulfide masked prodrug compositions and methods

#5757
20150314013
2015-11-05

Compositions and methods for polynucleotide transfection

#5758
20150314011
2015-11-05

Amphipathic peptide

#5759
20150313932
2015-11-05

Composition and method for treating a hematological malignancy

#5760
20150313893
2015-11-05

Nutlin-3A for treatment of proliferative vitreoretinopathy

#5761
20150313878
2015-11-05

Methods for diagnosing and treating prostate cancer

#5762
20150309037
2015-10-29

Treatment-induced damage to the tumor micro-environment promotes cancer therapy resistance through extracellular proteins

#5763
20150307937
2015-10-29

ACTIVITY-DEPENDENT GENE PAIRS AS THERAPEUTIC TARGETS AND METHODS AND DEVICES TO IDENTIFY THE SAME

#5764
20150307887
2015-10-29

FLT3 receptor antagonists for the treatment or the prevention of pain disorders

#5765
20150307885
2015-10-29

Multiple targeted RNAI for the treatment of cancers

#5766
20150307882
2015-10-29

RNAI-mediated inhibition of frizzled related protein-1 for treatment of glaucoma

#5767
20150307881
2015-10-29

UNA OLIGOMERS HAVING REDUCED OFF-TARGET EFFECTS IN GENE SILENCING

#5768
20150307880
2015-10-29

Transthyretin allele selective UNA oligomers for gene silencing

#5769
20150307879
2015-10-29

ANOIKIS RESISTANT PLACENTAL STEM CELLS AND USES THEREOF

#5770
20150307878
2015-10-29

RNA interference agent, method for producing same, and use therefor

#5771
20150307876
2015-10-29

DNA ASSIMILATION

#5772
20150307837
2015-10-29

Reprogramming of human whartons jelly cells to produce hair cells

#5773
20150307560
2015-10-29

Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof

#5774
20150306066
2015-10-29

Treatment of human cytomegalovirus by modulating Wnt

#5775
20150306036
2015-10-29

Nanoliposomal c-MYC-siRNA inhibits in vivo tumor growth of cisplatin-resistant ovarian cancer

#5776
20150301068
2015-10-22

MEANS AND METHOD FOR DIAGNOSIS AND TREATMENT OF ALZHEIMER'S DISEASE

#5777
20150299789
2015-10-22

Competitive modulation of microRNAs

#5778
20150299711
2015-10-22

Composition for treating cancer associated with HPV infection

#5779
20150299707
2015-10-22

Construction of pool of interfering nucleic acids covering entire RNA target sequence and related compositions

#5780
20150299706
2015-10-22

Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer

#5781
20150299703
2015-10-22

In vivo gene silencing by chemically modified and stable siRNA

#5782
20150299701
2015-10-22

Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor

#5783
20150299699
2015-10-22

MICROMIRs

#5784
20150299697
2015-10-22

Compositions and methods for inhibiting hypdxia induced damage

#5785
20150299696
2015-10-22

SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS

#5786
20150299336
2015-10-22

THERAPEUTIC AND DIAGNOSTIC TARGET GENE IN ACUTE MYELOID LEUKEMIA

#5787
20150297749
2015-10-22

LOW-DENSITY LIPOPROTEIN ANALOGUE NANOPARTICLES, AND COMPOSITION COMPRISING SAME FOR TARGETED DIAGNOSIS AND TREATMENT OF LIVER

#5788
20150297677
2015-10-22

Compositions and methods for inhibiting viral entry

#5789
20150297598
2015-10-22

Methods for treating renal disease

#5790
20150297597
2015-10-22

METHODS OF TREATMENT OF SKIN ULCERS

#5791
20150296757
2015-10-22

Animal model for type 2 diabetes and obesity

#5792
20150293099
2015-10-15

Method of treatment of SETDB1 expressing cancer

#5793
20150291964
2015-10-15

Methods and Compositions for treatment of cancer by inhibition of NR2F6

#5794
20150291963
2015-10-15

Sortilin 1 is a novel inducer of vascular calcification

#5795
20150291961
2015-10-15

RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX

#5796
20150291957
2015-10-15

METHODS AND COMPOSITIONS TO PRODUCE ss-RNAi ACTIVITY WITH ENHANCED POTENCY

#5797
20150291954
2015-10-15

Organic compositions to treat beta-catenin-related diseases

#5798
20150291698
2015-10-15

Methods and products for preventing and/or treating metastatic cancer

#5799
20150291691
2015-10-15

Methods for cancer management targeting Co-029

#5800
20150290343
2015-10-15

Exosome transfer of nucleic acids to cells

#5801
20150290340
2015-10-15

Short interference RNA gene delivery system for systemic circulation

#5802
20150290289
2015-10-15

Method of promoting wound healing

#5803
20150284726
2015-10-08

RNAi inhibition of alpha-ENaC expression

#5804
20150284723
2015-10-08

PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transition

#5805
20150284721
2015-10-08

Organic compositions to treat HSF1-related diseases

#5806
20150284717
2015-10-08

Therapeutics with conformationally restricted monomers

#5807
20150283256
2015-10-08

Poly(vinyl ester) polymers for in vivo nucleic acid delivery

#5808
20150283254
2015-10-08

Polymeric nanoparticles

#5809
20150283166
2015-10-08

Synergistic anti-cancer composition and a process for the preparation thereof

#5810
20150275230
2015-10-01

Method for establishing modified host cell

#5811
20150275220
2015-10-01

Carboxylated polyamine derivatives as transfection reagents

#5812
20150275218
2015-10-01

Organic compositions to treat beta-ENaC-related diseases

#5813
20150275214
2015-10-01

Delivery of dsRNA to arthropods

#5814
20150275206
2015-10-01

POLYMER CONJUGATES FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS

#5815
20150275189
2015-10-01

Polypeptides having peroxygenase activity

#5816
20150274815
2015-10-01

TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) INJURY

#5817
20150274779
2015-10-01

Compositions and methods for regulating arterial tone

#5818
20150273073
2015-10-01

Triazine cationic polymers and methods of use thereof

#5819
20150273054
2015-10-01

Modulation of CCR10 signals for treatment of skin and intestinal inflammatory diseases and infection

#5820
20150273034
2015-10-01

Globo H and related anti-cancer vaccines with novel glycolipid adjuvants

#5821
20150272984
2015-10-01

Agents for the prevention and/or treatment of central nervous system damage

#5822
20150272886
2015-10-01

Lipidosome preparation, preparation method and application thereof

#5823
20150267204
2015-09-24

Treatment of Sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a Sirtuin (SIRT)

#5824
20150267203
2015-09-24

RNA silencing in animals as an antiviral defense

#5825
20150267200
2015-09-24

RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)

#5826
20150267198
2015-09-24

Methods for treating apolipoprotein E4-associated disorders

#5827
20150267197
2015-09-24

Methods for modulating C9ORF72 expression

#5828
20150267196
2015-09-24

BIODEGRADABLE HYDROGEL FOR POLYNUCLEOTIDE DELIVERY

#5829
20150267194
2015-09-24

Double-stranded oligonucleotide molecules to DDIT4 and methods of use thereof

#5830
20150267184
2015-09-24

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#5831
20150266959
2015-09-24

Therapies based on control of regulatory T cell stability and function via a neuropilin-1:semaphorin axis

#5832
20150265708
2015-09-24

Lipids and compositions for the delivery of therapeutics

#5833
20150265684
2015-09-24

Methods of treating hemoglobinopathies

#5834
20150265587
2015-09-24

Androgen receptor variants and methods for making and using

#5835
20150259701
2015-09-17

GALL WASP CONTROL AGENTS

#5836
20150259692
2015-09-17

Composition and methods for the prevention and treatment of diet-induced obesity

#5837
20150259690
2015-09-17

AMPHIREGULIN-SPECIFIC DOUBLE-HELICAL OLIGO-RNA, DOUBLE-HELICAL OLIGO-RNA STRUCTURE COMPRISING DOUBLE-HELICAL OLIGO-RNA, AND COMPOSITION FOR PREVENTING OR TREATING RESPIRATORY DISEASES CONTAINING SAME

#5838
20150259689
2015-09-17

Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (miR145) and micro-RNA 212 (miR212)

#5839
20150259686
2015-09-17

NICKED OR GAPPED NUCLEIC ACID MOLECULES AND USES THEREOF

#5840
20150259685
2015-09-17

Treatment of uncoupling protein 2 (UCP2) related diseases by inhibition of natural antisense transcript to UCP2

#5841
20150259683
2015-09-17

AGENT FOR TREATING RENAL FIBROSIS

#5842
20150259682
2015-09-17

Gene silencing methods

#5843
20150259678
2015-09-17

Hydroxylated polyamine derivatives as transfection reagents

#5844
20150259677
2015-09-17

SiRNA and their use in methods and compositions for the treatment and/or prevention of eye conditions

#5845
20150259675
2015-09-17

Short interfering ribonucleic acid (siRNA) for oral administration

#5846
20150259651
2015-09-17

Polypeptides having peroxygenase activity

#5847
20150259429
2015-09-17

CLUSTER OF DIFFERENTIATION 36 (CD36) AS A THERAPEUTIC TARGET FOR HIV INFECTION

#5848
20150259399
2015-09-17

Antibodies and processes for preparing the same

#5849
20150258213
2015-09-17

Nanotubes as carriers of nucleic acids into cells

#5850
20150258175
2015-09-17

Method of treating cancer

#5851
20150258168
2015-09-17

MODULATION OF PODOPLANIN MEDIATED PLATELET ACTIVATION

#5852
20150258094
2015-09-17

Nanocarriers and their processing for diagnostics and therapeutics

#5853
20150252372
2015-09-10

PREPARATION OF ANTIBODY OR AN ANTIBODY FRAGMENT TARGETED IMMUNOLIPOSOMES FOR SYSTEMIC ADMINISTRATION OF THERAPEUTIC OR DIAGNOSTIC AGENTS AND USES THEREOF

#5854
20150252371
2015-09-10

Splice Switching Oligomers for TNF Superfamily Receptors and Their Use in Treatment of Disease

#5855
20150252369
2015-09-10

METHODS AND COMPOSITIONS FOR ENHANCING DELIVERY OF DOUBLE-STRANDED RNA OR A DOUBLE-STRANDED HYBRID NUCLEIC ACID TO REGULATE GENE EXPRESSION IN MAMMALIAN CELLS

#5856
20150252368
2015-09-10

Targets in multiple myeloma and other disorders

#5857
20150252367
2015-09-10

Modulation of transthyretin expression

#5858
20150252112
2015-09-10

Methods for treating and/or limiting development of diabetes

#5859
20150250898
2015-09-10

NANOCOMPOSITES FOR IMAGING AND DRUG DELIVERY

#5860
20150250853
2015-09-10

METHODS AND COMPOSITIONS FOR MODIFYING THE IMMUNE RESPONSE

#5861
20150247859
2015-09-03

Use of isocitrate dehydrogenase 1 as a diagnostic and prognostic biomarker and therapeutic target for lung cancers

#5862
20150247855
2015-09-03

Method for the treatment of cardiovascular fibrosis

#5863
20150247206
2015-09-03

Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer Metastasis

#5864
20150247148
2015-09-03

COMPOSITION FOR SUPPRESSING EXPRESSION OF TARGET GENE

#5865
20150247143
2015-09-03

Complement component C5 iRNA compositions and methods of use thereof

#5866
20150246134
2015-09-03

Biotin complexes for treatment and diagnosis of alzheimer's disease

#5867
20150246118
2015-09-03

LYVE-1 ANTAGONISTS FOR PREVENTING OR TREATING A PATHOLOGICAL CONDITION ASSOCIATED WITH LYMPHANGIOGENESIS

#5868
20150240313
2015-08-27

Use of ADCY3 for diagnosis and treatment of gastric cancer

#5869
20150240258
2015-08-27

Compositions and methods for controlling

#5870
20150240242
2015-08-27

Compositions And Methods For Inhibiting Expression Of IKK-B Gene

#5871
20150240241
2015-08-27

Pain treatment using ERK2 inhibitors

#5872
20150240238
2015-08-27

THERAPEUTIC RNA SWITCHES COMPOSITIONS AND METHODS OF USE

#5873
20150240237
2015-08-27

Compositions and Methods for Inhibiting Expression of a Gene from the JC Virus

#5874
20150240236
2015-08-27

Recombinant RNA particles and methods of use

#5875
20150240235
2015-08-27

Methods for producing a population of pancreatic beta-cells

#5876
20150240234
2015-08-27

Methods and compositions for the specific inhibition of MYC by double-stranded RNA

#5877
20150240218
2015-08-27

Polypeptides having peroxygenase activity

#5878
20150239964
2015-08-27

Use of regulatory T cell-specific surface protein LRIG-1

#5879
20150239926
2015-08-27

Asymmetric ionizable cationic lipid for RNA delivery

#5880
20150239834
2015-08-27

Ionizable cationic lipid for RNA delivery

#5881
20150238619
2015-08-27

POLYMERIC CARRIER

#5882
20150238569
2015-08-27

Use of miR-494 to modulate TRAIL-induced apoptosis through BIM down-regulation

#5883
20150238517
2015-08-27

Methods and compositions for treating cancer

#5884
20150238516
2015-08-27

Polynucleotides having bioreversible groups

#5885
20150238515
2015-08-27

ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES

#5886
20150232859
2015-08-20

Nucleic acid molecules that target the vacuolar atpase C subunit and confer resistance to coleopteran pests

#5887
20150232856
2015-08-20

TELOMERASE INHIBITORS FOR USE IN THERAPY

#5888
20150232855
2015-08-20

Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors

#5889
20150232851
2015-08-20

UNA oligomers targeting micro-RNA for therapeutics

#5890
20150232849
2015-08-20

UNA duplex oligomers for therapeutics

#5891
20150232848
2015-08-20

Methods targeting miR-128 for regulating cholesterol/lipid metabolism

#5892
20150232843
2015-08-20

Compositions and methods for treatment of prostate and other cancers

#5893
20150232840
2015-08-20

Methods and compositions for treating neurological disease

#5894
20150232838
2015-08-20

EFFECTS OF APOLIPOPROTEIN B INHIBITION ON GENE EXPRESSION PROFILES IN ANIMALS

#5895
20150232513
2015-08-20

Compositions and methods for treating hepatitis B

#5896
20150231254
2015-08-20

POLYNUCLEOTIDE-POLY(DIOL) CONJUGATES, PROCESS OF PREPARATION AND USES THEREOF

#5897
20150231203
2015-08-20

Treatment of pain by inhibition of USP5 de-ubiquitinase

#5898
20150225738
2015-08-13

Transgenic plant of the species solanum tuberosum with resistance to phytophthora

#5899
20150225725
2015-08-13

Treatment of fibroblast growth factor 21 (FGF21) related diseases by inhibition of natural antisense transcript to FGF21

#5900
20150225724
2015-08-13

Treatment of adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an adiponectin (ADIPOQ)

#5901
20150225723
2015-08-13

Gene nanocomposite, and cellular internalization method of gene using same

#5902
20150225720
2015-08-13

RNAi Inhibition of Serum Amyloid A For Treatment of Glaucoma

#5903
20150225717
2015-08-13

Selective reactivation of genes on the inactive X chromosome

#5904
20150225702
2015-08-13

Adeno-associated virus virions with variant capsid and methods of use thereof

#5905
20150225469
2015-08-13

Method for regulating cell proliferation

#5906
20150224334
2015-08-13

Pharmaceutical composition and uses thereof

#5907
20150224142
2015-08-13

Inhibition of diacylglycerol kinase to augment adoptive T cell transfer

#5908
20150224131
2015-08-13

SiRNA and their use in methods and compositions for the treatment and / or prevention of eye conditions

#5909
20150218564
2015-08-06

Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell

#5910
20150218563
2015-08-06

COMPOSITIONS AND METHODS FOR MODULATION OF RORGAMMAT FUNCTIONS

#5911
20150218557
2015-08-06

RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end

#5912
20150218556
2015-08-06

Compositions and methods for treating peripheral arterial disease

#5913
20150218552
2015-08-06

RNAI BASED SELECTION SYSTEM

#5914
20150218529
2015-08-06

Polypeptides having peroxygenase activity

#5915
20150218514
2015-08-06

PROMOTER OF DIFFERENTIATION FROM HEPATIC PROGENITOR CELL INTO HEPATIC CELL, AND USE THEREOF

#5916
20150216991
2015-08-06

Compositions for the delivery of RNA and drugs into cells

#5917
20150216899
2015-08-06

Exosome-based therapeutics against neurodegenerative disorders

#5918
20150216891
2015-08-06

Nucleic acids targeting TCTP for use in the treatment of chemo- or hormone-resistant cancers

#5919
20150216803
2015-08-06

Lipid assemblies comprising anionic lysolipids and use thereof

#5920
20150212088
2015-07-30

Compositions and methods for detecting and treating colorectal cancer

#5921
20150212086
2015-07-30

Diagnosis and treatment of brain tumor

#5922
20150211070
2015-07-30

COMPOSITIONS AND METHODS FOR ANALYZING HETEROGENEOUS SAMPLES

#5923
20150211008
2015-07-30

Post-synthetic chemical modification of RNA at the 2′-position of the ribose ring via “click” chemistry

#5924
20150211007
2015-07-30

Selective inhibition of polyglutamine protein expression

#5925
20150211006
2015-07-30

Chiral control

#5926
20150211004
2015-07-30

RNAI-BASED THERAPIES FOR CARDIOMYOPATHIES, MUSCULAR DYSTROPHIES AND LAMINOPATHIES

#5927
20150210760
2015-07-30

Therapeutic method for pancreatic cancer

#5928
20150209441
2015-07-30

Anandamide-modified nucleic acid molecules

#5929
20150209440
2015-07-30

CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS OF USE

#5930
20150209369
2015-07-30

Combination Therapy III

#5931
20150209283
2015-07-30

PROCESSES AND COMPOSITIONS FOR LIPOSOMAL AND EFFICIENT DELIVERY OF GENE SILENCING THERAPEUTICS

#5932
20150204874
2015-07-23

Predicting and treating diabetic complications

#5933
20150204846
2015-07-23

PHOSPHATIDYLINOSITOL-3-KINASE C2 BETA MODULATORS AND METHODS OF USE THEREOF

#5934
20150203867
2015-07-23

Compositions and methods for controlling

#5935
20150203852
2015-07-23

Inhibition of oxidative stress in atrial fibrillation

#5936
20150203851
2015-07-23

INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN PCAF FOR THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES OR FOR THE TREATMENT OF CANCER

#5937
20150203848
2015-07-23

CTLA-4 aptamer siRNA species

#5938
20150203847
2015-07-23

CHEMICAL MODIFICATIONS OF MONOMERS AND OLIGONUCLEOTIDES WITH CYCLOADDITION

#5939
20150203846
2015-07-23

Treatment of Myelodysplastic Syndrome by Inhibition of NR2F6

#5940
20150203845
2015-07-23

Double-stranded oligonucleotide molecules to P53 and methods of use thereof

#5941
20150203843
2015-07-23

Tetragalnac containing conjugates and methods for delivery of oligonucleotides

#5942
20150203842
2015-07-23

Co-transcriptional assembly of modified RNA nanoparticles

#5943
20150203831
2015-07-23

Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same

#5944
20150203446
2015-07-23

Di-aliphatic substituted pegylated lipids

#5945
20150203439
2015-07-23

Aminoalcohol lipidoids and uses thereof

#5946
20150202298
2015-07-23

Compositions for targeted delivery of siRNA

#5947
20150198613
2015-07-16

Soluble MANF in pancreatic β-cell disorders

#5948
20150197756
2015-07-16

Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA

#5949
20150197755
2015-07-16

EpCAM aptamer for detection of cancer stem cells

#5950
20150197754
2015-07-16

Multi-conjugate of siRNA and preparing method thereof

#5951
20150197751
2015-07-16

RNAI EXPRESSION CONSTRUCTS

#5952
20150197749
2015-07-16

Structurally designed shRNAs

#5953
20150197748
2015-07-16

Oral delivery of nucleic acid-based gene interfering agents by

#5954
20150197747
2015-07-16

Agent for treating cancer

#5955
20150197746
2015-07-16

Modified RNAi agents

#5956
20150196648
2015-07-16

Methods and compositions for treating prostate cancer

#5957
20150191732
2015-07-09

LEPIDOPTERAN INSECT N-ACETYLGLUCOSAMINIDASE GENES AND THEIR USE IN GLYCOENGINEERING

#5958
20150191731
2015-07-09

Therapeutic alteration of transplantable tissues through or exposure to RNA interference molecules

#5959
20150191730
2015-07-09

Aptamer-targetted antigen delivery

#5960
20150191729
2015-07-09

Composition comprising material for inhibiting SCF or receptor thereof for treating or preventing diseases associated with vascular permeability

#5961
20150191728
2015-07-09

Recombinant DNA for gene suppression

#5962
20150191726
2015-07-09

Ligand-conjugated monomers

#5963
20150190515
2015-07-09

Lipid compositions

#5964
20150190419
2015-07-09

Method to treat or prevent herpesvirus infections

#5965
20150190391
2015-07-09

INHIBITORS OF NKX2.5 FOR VASCULAR REMODELLING

#5966
20150185223
2015-07-02

Compositions Comprising RAC Mutants, and Methods of Use Thereof

#5967
20150185202
2015-07-02

Simultaneous detection of cannibalism and senescence as prognostic marker for cancer

#5968
20150184167
2015-07-02

Bacteria mediated gene silencing

#5969
20150184163
2015-07-02

Diagnostic and screening methods for atopic dermatitis

#5970
20150184161
2015-07-02

EML4-ALK fusion gene

#5971
20150184160
2015-07-02

Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA

#5972
20150184159
2015-07-02

USE OF COX-3 BINDING MOLECULES FOR MODULATING AUTOPHAGY

#5973
20150184158
2015-07-02

TRANSLOCATION AND MUTANT ROS KINASE IN HUMAN NON-SMALL CELL LUNG CARCINOMA

#5974
20150184154
2015-07-02

NEW TREATMENT FOR NEURODEGENERATIVE DISEASES

#5975
20150182624
2015-07-02

Use of nanodiamonds for generating free radicals for therapeutic purposes under radiation

#5976
20150177248
2015-06-25

Use of SIRT7 as novel cancer therapy target and method for treating cancer using the same

#5977
20150176025
2015-06-25

Ras opposite (ROP) and related nucleic acid molecules that confer resistance to coleopteran and/or hemipteran pests

#5978
20150176024
2015-06-25

TARGET GENES FOR CONTROL OF PLANT PARASITIC NEMATODES AND USE OF SAME

#5979
20150176011
2015-06-25

Methods of identifying and treating glioblastoma

#5980
20150176009
2015-06-25

Nucleic acid molecules that confer resistance to coleopteran pests

#5981
20150176008
2015-06-25

Methods of inducing insulin production

#5982
20150175973
2015-06-25

Highly efficient method for establishing induced pluripotent stem cell

#5983
20150174261
2015-06-25

Cationic lipid

#5984
20150174222
2015-06-25

MODIFICATION OF THE IMMUNOMODULATORY EFFECTS OF CELLS

#5985
20150174138
2015-06-25

Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy

#5986
20150167006
2015-06-18

Oligomeric compounds and methods

#5987
20150167002
2015-06-18

RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS

#5988
20150167001
2015-06-18

Repressor on IFN-λ promoter and siRNA against GATA1, EVI1, and CRX to alter IFN-λ gene activity

#5989
20150166998
2015-06-18

Aptamer-mRNA conjugates for targeted protein or peptide expression and methods for their use

#5990
20150166994
2015-06-18

Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG

#5991
20150166991
2015-06-18

METHODS FOR TREATING MDS1-EVI1 MEDIATED CANCER

#5992
20150166990
2015-06-18

Therapeutic oligonucleotides comprising pyrazolotriazine nucleotide analogues

#5993
20150166989
2015-06-18

Particle-nucleic acid conjugates and therapeutic uses related thereto

#5994
20150166642
2015-06-18

METHODS AND COMPOSITIONS FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR-1alpha (PGC1alpha) AS A TARGET OF CIRCULATING TUMOR CELLS

#5995
20150166465
2015-06-18

Lipid formulations

#5996
20150165066
2015-06-18

Low density lipoprotein receptor-mediated siRNA delivery

#5997
20150165039
2015-06-18

Stable non-aggregating nucleic acid lipid particle formulations

#5998
20150164987
2015-06-18

Wnt signaling inhibitor comprising insulin-like growth factor-binding protein

#5999
20150164934
2015-06-18

Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancer

#6000
20150164799
2015-06-18

Lipid formulations for nucleic acid delivery